Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial

Diabetic Medicine - United Kingdom
doi 10.1111/j.1464-5491.2010.03020.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Randomized, Double-Blind, Placebo-Controlled Trial of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Asian Patients With Type 2 Diabetes Insufficiently Controlled on Basal Insulin With or Without a Sulfonylurea (GetGoal-L-Asia)

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Effect of Adding Insulin Degludec to Treatment in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Liraglutide: A Double-Blind Randomized Controlled Trial (BEGIN: ADD TO GLP-1 Study)

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2017English

Effect of a Dual PPAR Α/Γ Agonist on Insulin Sensitivity in Patients of Type 2 Diabetes With Hypertriglyceridemia- Randomized Double-Blind Placebo-Controlled Trial

Scientific Reports
Multidisciplinary
2019English

Effect of Linagliptin and Voglibose on Metabolic Profile in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

BMC pharmacology & toxicology
MedicinePharmacology
2018English

A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of Hydroxychloroquine in Patients With Type 2 Diabetes Mellitus

Global Journal of Endocrinological Metabolism
2018English

Adherence to GLP-1 Receptor Agonist Therapy Administered by Once-Daily or Once-Weekly Injection in Patients With Type 2 Diabetes in Germany

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2016English

Corrections To: Once-Daily Controlled-Release Pregabalin in the Treatment of Patients With Fibromyalgia: A Phase III, Double-Blind, Randomized Withdrawal, Placebo-Controlled Study

Current Medical Research and Opinion
Medicine
2017English

Effects of a Motilin Receptor Agonist (ABT-229) on Upper Gastrointestinal Symptoms in Type 1 Diabetes Mellitus: A Randomised, Double Blind, Placebo Controlled Trial

Gut
Gastroenterology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy